谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Supplemental Table 3 from Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Small Cell Lung Cancer Cohort

Makoto Nishio,Shuji Murakami,Hisato Kawakami,Kyoichi Okishio,Motohiro Tamiya,Hiroyoshi Kobayashi,Daichi Fujimoto,Shunichi Sugawara,Toshiyuki Kozuki,Yuko Oya,Hiroki Izumi,Takayuki Shiroyama,Miyako Satouchi,Noboru Yamamoto, Shota Kaname,Daiko Matsuoka,Yohei Otake,Takao Takase,Taro Semba,Koichi Azuma

openalex

引用 0|浏览0
暂无评分
摘要
Supplementary Table 3. Anticancer Therapies Received During Survival Follow-up
更多
查看译文
关键词
Tumor Microenvironment,Tumor Markers
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要